Abstract
Improvement in supportive care including the introduction of new antibiotics, antiviral and antifungal agents and haematopoietic growth factors have all contributed to a decreased chemotherapy-related mortality and morbidity in cancer patients. However, infections/septic shock during neutropenia still constitutes a major threat to these patients. Most patients develop fever during neutropenia and in 20–40% a manifest bacteremia is documented. In patients with prolonged neutropenia, the risk for fungal infections is increased. The spectrum of bacterial, fungal and viral infections in the neutropenic patient is reviewed.
Article PDF
Similar content being viewed by others
References
Bodey, G.P., Buckley, M., Sathe, Y.S. and Freireich, E.J. (1966) Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia.Medicine 64, 328–40.
Hughes, W.T., Armstrong, D., Bodey, G.P., Feld, R., Mandell, G.L., Mayers, J.D., Pizzo, P.A., Schimpff, S.C., Shenep, J.L., Wade, J.C., Young, L.S. and Yow, M.D. (1990) Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever.J. Infect. Dis. 161, 381–96.
Pizzo, P.A., Hathorn, J.W., Hiemenz, J., Browne, M., Commers, J., Cotton, D., Gress, J., Longo, D., Marshall, D., McKnight, J., Rubin, M., Skeleton, J., Thaler, M. and Wesley, R. (1986) A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia.N. Engl. J.Med. 315, 552–8.
Kinsey, S.E., Machin, S.J. and Goldstone, A.H. (1990) Ceftazidime monotherapy is as effective as ceftazidime combined with gentamicin in the treatment of febrile neutropenic patients.J. Hosp. Infect. 15, 49–53.
EORTC International Antimicrobial Therapy Cooperative Group and the National Cancer Institute of Canada — Clinical Trials Group (1991) Vancomycin added to empirical combination antibiotic therapy for fever in granulocy- topenic cancer patients.J. Infect Dis. 163, 951–8.
De Pauw, B.E., Deresinski, S.C., Feld, R., Lane-Allman, E.F. and Donnelly, P. (1994) Ceftazidime compared with piperacillin and tobramycin for empiric treatment of fever in neutropenic patients with cancer.Ann. Intern. Med. 120, 834–44.
McGowan, J.E., Barnes, M.W. and Finland, M. (1975) Bacteremia at Boston City Hospital: occurrence and mortality during 12 selected years (1935-1972), with special reference to hospital acquired cases.J. Infect. Dis. 132, 316–35.
Schwartz, R.S., Machintoch, F.R., Schrier, S.L. and Greenberg, P.L. (1984) Multivariate analysis of factors associated with invasive fungal disease during remission induction therapy for acute myelogenous leukemia.Cancer 53, 411–9.
Klastersky, J. (1993) Fever and neutropenia during intensive chemotherapy.Ann. Oncol. 4, 603–6.
Pizzo, P. (1993) Management of fever in patients with cancer and treatment induced neutropenia.N. Engl. J. Med. 328, 1323–32.
Fredlund, H., Björeman, M., Kjellander, J., Sjöberg, L., Bjorne, L. and Öhlin, A-L. (1990) A 10-year survey of clinically significant blood culture isolates and antibiotic susceptibilities from adult patients with hematological diseases at a major Swedish hospital.Scand. J. Infect. Dis. 22, 381–91.
Rintala, E. (1994) Incidence and clinical significance of positive blood cultures in febrile episodes of patients with haematological malignancies.Scand. J. Infect. Dis. 26, 77–84.
Tancrède, C.H. and Andremont, A.O. (1985) Bacterial translocation and gram-negative bacteremia in patients with hematological malignancies.J. Infect. Dis. 152, 99–103.
Schimpff, S.C., Young, V.M., Green, W.H., Vermeulen, G., Moody, M. and Wiernik, P. (1972) Origin of infection in acute nonlymphocytic leukemia. Significance of hospital acquisition of potential pathogens.Ann. Intern. Med. 77, 707–14.
Bodey, G.P., Jadeja, L. and Elting, L. (1985)Pseudomonas bacteremia: Retrospective analysis of 410 episodes.Arch. Intern. Med. 145, 1621–9.
Bodey, G.P., Elting, L., Kassamali, H. and Poh Lim, B. (1986)Escherichia coli bacteremia in cancer patients.Am. J. Med. 81, 85–95.
Günther, G., Björklind, A., Engervall, P., Björkholm, M. and Stiernstedt, G. (1991) Septicemia in patients with hematological disorders and neutropenia. A retrospective study of causative agents and their resistance profile.Scand. J. Infect. Dis. 23, 589–98.
Fast, D.J., Schlievert, P.M. and Nelson, R.D. (1989) Toxic shock syndrome-associated staphylococcal and streptococcal pyrogenic toxins are potent inducers of tumor necrosis factor production.Infect. Immun. 57, 292–4.
Martin, M.A., Pfaller, M.A. and Wenzel, R.P. (1989) Coagulase-negative staphylococcal bacteremia. Mortality and hospital stay.Ann. Intern. Med. 110, 9–16.
Wade, J.C, Schimpff, S.C., Newman, K.A. and Wiernik, P.H. (1982)Staphylococcus epidermidis: an increasing cause of infection in patients with granulocytopenia.Ann. Intern. Med. 97, 503–8.
Refsahl, K. and Andersen, B.M. (1992) Clinically significant coagulase-negative staphylococci: identification and resistance patterns.J. Hosp. Infect. 22, 19–31.
Bochud, P.-Y., Calandra, T. and Francioli, P. (1994) Bacteremia due to viridans streptococci in neutropenic patients: a review.Am. J. Med. 97, 256–64.
Elting, L.S., Bodey, G.P. and Keefe, B.H. (1992) Septicemia and shock syndrome due to viridans streptococci: a case-control study of predisposing factors.Clin. Infect. Dis. 14, 1201–7.
Brown, E.A., Talbot, G.H., Provencher, M. and Cassileth, P. (1989) Anaerobic bacteremia in patients with acute leukemia.Infect. Contr. Hosp. Epidemiol. 10, 65–9.
Glenn, J., Cotton, D., Wesly, R. and Pizzo, P.A. (1988) Anorectal infections in patients with malignant diseases.Rev. Infect. Dis. 10, 42–52.
Zetterberg, G., Bjorkholm, M., Farnebo, L.-O. and Eklund, A.-E. (1987) Acute abdominal pain in the granulocytopenic patient — a clinical dilemma. (Swedish).Lakartidningen 84, 4248–9.
Wade, D.S., Nava, H.R. and Douglass, H.O. (1992) Neutropenic enterocolitis.Cancer 69, 17–23.
Kelly, C.P., Pothoulakis, C. and LaMont, J.T. (1994)Clostridium difficile colitis.N. Engl. J. Med. 330, 257–62.
Panichi, G., Pantosti, A., Gentile, G., Testore, G.P., Venditti, M., Martino, P. and Serras, P. (1985)Clostridium difficile colitis in leukemia patients.Eur. J. Cancer. Clin. Oncol. 21, 1159–63.
Rampling, A., Waren, R.E., Beven, P.C., Hoggart, C.E., Swirsky, D. and Hayhoe, G J. (1985)Clostridium difficile in haematological malignancy.J. Clin. Pathol. 38, 445–51.
Engervall, P., Björkholm, M., Petrini, B., Heurlin, N., Henriques, B. and Kallenius, G. (1993) Disseminated mycobacterium malmoense infection in a patient with chronic granulocytic leukemia.J. Int. Med. 234, 231–3.
Vilalta-Castel, E., Valdés-Sanchez, M.D., Guerra-Vales, J.M., Teno-Esteban, C., Garzón, A., Lopez, J.I., Ricard, M.P., Abarca, M. and Juan de Garcia-Dias, D. (1988) Significance of granulomas in the bone marrow.Eur. J. Haematol. 41, 12–6.
Gerson, S.L., Talbot, G.H., Hurwitz, S., Strom, B.L., Lusk, E.J. and Cassileth, P.A. (1984) Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia.Ann. Intern. Med. 100, 345–51.
Anaissie, E. and Bodey, G.P. (1989) Nosocomial fungal infections. Old problems and new challenges.Infect. Dis. Clin. North Am. 3, 867–82.
Saral, R. (1991) Candida and Aspergillus infections in immunocompromised patients.Rev. Infect. Dis. 13, 487–92.
Meunier, F. and Wong, B. (1993) Overview of management of fungal infections: Part 1.Clin. Infect. Dis. 17, 492–3.
Shepp, D.H., Kosterman, A., Siegel, M.S. and Meyers, J.D. (1985) Comparative trial of ketoconazole and nystatin for the prevention of fungal infection in neutropenic patients treated within protected environment.J. Infect. Dis. 152, 1257–63.
Wingard, J.R., Merz, W.G., Rinaldi, M.G., Johnsson, T.R., Karp, J.E. and Saral, R. (1991) Increase inCandida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole.N. Engl. J. Med. 325, 1274–7.
Björkholm, M., Engervall, P. and Grimfors, G. (1994) Fungal infections in neutropenic patients. Necessary with adequate prophylaxis. (Swedish)Lakartidningen 91, 4492–4.
Goodman, J.L., Winston, D.J., Greenfield, R.A., Chandraskar, P.H., Fox, B., Kaizer, H., Shadduck, R.K., Shea, T.C., Stiff, P., Friedman, D.J., Powderly, W.G., Silber, P., Horowitz, H., Lichtin, A., Wolff, S.N., Mangan, K.F., Silver, S.M., Weisdorf, D., Ho, W.G., Gilbert, G. and Buell, D. (1992) A controlled trial of fluconazole to prevent infections in patients undergoing bone marrow transplantation.N. Engl J. Med. 326, 845–51.
Wiley, J.M., Smith, N., Leventhal, B.G., Graham, M.L., Strauss, L.C., Hurwitz, C.A., Modlin, J., Mellits, D., Baumgardner, R., Corden, BJ. and Civin, C.L. (1990) Invasive fungal disease in pediatric acute leukemia patients with fever and neutropenia during induction chemotherapy: A multivariate analysis of risk factors.J. Clin. Oncol. 8, 280–6.
Maschmayer, G., Link, H., Hiddemann, W., Meyer, P., Helmerking, M., Eisenmann, E., Schitt, J. and Adam, D. (1994) Pulmonary infiltrations in febrile patients with neutropenia.Cancer 73, 2296–304.
Tollemar, J. (1991)Invasive fungal infections. Incidence, diagnosis, risk-factors and treatment in bone marrow and liver transplant recipients. Thesis, Karolinska Institute.
Walsh, T.J., Hathorn, J.W., Sobel, J.D., Merz, W.G., Sanchez, V., Maret, S.M., Buckley, H.R., Pfaller, M.A., Schaufele, R., Sliva, C., Navarro, E., Lecciones, J., Chandrasekar, P., Lee, J. and Pizzo, P.A. (1991) Detection of circulating Candida enolase by immunoassay in patients with cancer and invasive candidiasis.N. Engl J. Med. 324, 1026–31.
Swerdloff, J.N., Filler, S.G. and Edwards, J.E. (1993) Severe Candidal infections in neutropenic patients.Clin. Infect. Dis. 17, S457–67.
Haron, E., Feld, R., Tuffnell, P., Patterson, B., Hasselback, R. and Matlow, A. (1987) Hepatic candidiasis: an increasing problem in immunocompromised patients.Am. J. Med. 83, 17–26.
Björkholm, M., Kållberg, N., Grimfors, G., Eklund, L.H., Eksborg, S., Juneskans, O.T. and Udén, A.-M. (1991) Successful treatment of hepatosplenic candidiasis with a liposomal amphotericin B preparation. A case report.J. Intern. Med. 230, 173–7.
Pannuti, C.S., Gringrich, D.R., Pfaller, M.A. and Wenzel, R.P. (1991) Nosocomial pneumonia in adult patients undergoing bone marrow transplantation.J. Clin. Oncol. 9, 77–84.
Fischer, B.D., Armstrong, D., Yu, B. and Gold, J.W. (1981) Invasive pulmonary Aspergillosis in early diagnosis and treatment.Am. J. Med. 71, 571–7.
Gerson, S.L., Talbot, G.H. and Lusk, E. (1985) Invasive pulmonary Aspergillosis in adult acute leukemia: clinical clues to its diagnosis.J. Clin. Oncol. 3, 1109–16.
Kuhlman, J.E., Bruch, P.A. and Zerhouni, E.A. (1987) Invasive pulmonary Aspergillosis in acute leukemia. The contribution of CT to early diagnosis and aggressive management.Chest 92, 95–9.
Singer, C., Armstrong, D., Rosen, P.P. and Schottenfeld, D. (1975) Pneumocystis carinii pneumonia: a cluster of eleven cases.Ann. Intern. Med. 82, 772–7.
Hughes, W.T. (1987) Pneumocystis carinii pneumonitis.N. Engl J. Med. 317, 1021–3.
Muller, S.A., Herreman, Jr. C.C. and Winkelmann, R.K. (1972) Herpes simplex infections in hematological malignancies.Am. J. Med. 52, 102–14.
Baglin, T.P., Gray, J.J., Marcus, R.E. and Wreghitt, T.G. (1989) Antibiotic resistant fever associated with herpes simplex virus infection in neutropenic patients with haematological malignancy.J. Clin. Pathol. 42, 1255–8.
Hirsch, M.S. (1988) Herpes group viruses infections in the compromised host. In R.H. Rubin and L.S. Young (eds)Clinical approach to infections in the compromised host, pp. 347–66. New York: Plenum.
Saral, R., Burns, W.H., Laskin, O.L., Santos, G.W. and Lietman, P.S. (1981) Acyclovir prophylaxis of herpes-simplex-virus infections: a randomized, double-blind, controlled trial in bone-marrow-transplant recipients.N. Engl J. Med. 305, 63–7.
Meyers, J.D., Reed, E.C, Shepp, D.H., Thornquist, M., Dandliker, P.S., Vicary, C.A., Flournoy, N., Kirk, L.E., Kersey, J.H., Thomas, E.D. and Balfour, H.H. (1988) Acyclovir for prevention of cytomegalovirus infection and disease after allogeneic marrow transplantation. N.Engl J. Med. 318, 70–5.
Lönnquist, B., Palmblad, J., Grimfors, G., Jarnmark, M., Lernaer, R., Ljungman, P., Nyström-Rosander, C. and Öberg, G. (1993) Oral acyclovir prophylaxis for bacterial infections during induction therapy for acute leukemia in adults.Support Care Cancer 1, 139–44.
Forman, S.J. and Zaia, J.A. (1994) Treatment and prevention of cytomegalovirus pneumonia after bone marrow transplantation: where do we stand?Blood 83, 2392–8.
Gruber, A., Norder, A., Magnius, L., Rotzén, M., Rubio, C., Grillner, L. and Björkholm, M. (1993) Late seroconversion and high chronicity rate of hepatitis C virus infection in patients with hematological disorders.Ann. Oncol. 4, 229–34.
Allander, T., Gruber, A., Naghavi, M., Beyene, A., Söderstrom, T., Bjorkholm, M., Grillner, L. and Persson, M.A.A. (1995) Frequent patient-to-patient transmission of hepatitis C virus in a Haematology ward.Lancet 345, 603–6.
Aschan, J., Ringdén, O., Ljungman, P., Andersson, J., Lewensohn-Fuchs, I. and Forsgren, M. (1989) Influenza B in transplant patients.Scand. J. Infect. Dis. 21, 349–50.
Ljungman, P., Andersson, J., Aschan, J., Barkholt, L., Ehrnst, A., Johansson, M. and Weiland, O., (1993) Influenza A in immunocompromised patients.Clin. Infect. Dis. 17, 244–7.
Klastersky, J. (1992) Febrile neutropenia. Focus on antibacterial therapy. InConsultant series. Macclesfield, Gardiner-Caldwell Communications Ltd.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Engervall, P., Björkholm, M. Infections in neutropenic patients I: Aetiology. Med Oncol 12, 251–256 (1995). https://doi.org/10.1007/BF02990570
Issue Date:
DOI: https://doi.org/10.1007/BF02990570